Alexander Koglin, PhD
Alex received his PhD in biophysical chemistry from the University in Frankfurt/ Main, Germany. He was a Postdoc at the Harvard Medical School in Boston, MA, and an Oppenheimer Fellow at the Los Alamos National Laboratory in Los Alamos, NM. Alex focuses on bioinformatic analysis of natural product biosynthetic clusters.
Michael Humbert, PhD
Michael received his PhD in biochemistry from the University in Frankfurt/Main, Germany. He was a Research Fellow and Instructor at the Dana-Farber Cancer Institute and Harvard Medical School in Boston, MA, working on vaccine design and antibody development. In recent years, he developed diagnostic antibodies for blood tests.
Chief Commercial Officer
Joseph has over 25 years of pharmaceutical and biotechnology experience successfully commercializing new vaccines, biologics and pharmaceuticals. Prior to Nature’s Toolbox (NTx), he was responsible for Commercial Strategy and Business Development at IMV, Inc. and spent most of his career in the vaccine division of Merck & Co, Inc. in West Point, PA. He has a BA from Hamilton College in Clinton New York and an MBA from Cornell University in Ithaca New York.
Former Director, Los Alamos National Laboratory
Charles F. McMillan served as Principal Associate Director for Weapons Programs at Los Alamos National Laboratory (LANL), directing the science, technology, engineering, and infrastructure that enables LANL to deliver on its core mission of ensuring the safety, reliability, and performance of the nation’s nuclear deterrent. Prior to joining Los Alamos National Laboratory, McMillan served as B Division Leader at Lawrence Livermore National Laboratory in California. With 35-years of leadership and technical career experience at two National Laboratories, he advises the Department of Defense (DoD), Department of Energy (DOE), laboratories, and industry on a variety of strategic subjects. He holds a Doctorate in Physics from the Massachusetts Institute of Technology and a Bachelor of Science in Mathematics and Physics from Washington Adventist University.
Former U.S. Assistant Secretary of Defense for Nuclear, Chemical & Biological Defense Programs
Hon. Andy Weber is an independent consultant and a Senior Fellow at the Council on Strategic Risks, a non-partisan, non-profit think tank. He has dedicated his professional life to countering nuclear, chemical, and biological threats and to strengthening global health security. Weber’s thirty years of US government service included five-and-a-half years as President Obama’s Assistant Secretary of Defense for Nuclear, Chemical and Biological Defense Programs. Weber is currently a Strategic Advisor for Ginkgo BioWorks and consultant for DARPA, Lawrence Livermore National Laboratory, among others. He serves on the Boards of the Arms Control Association and Healthcare Ready, and the James Martin Center for Non-proliferation Studies International Advisory Council and was a Senior Fellow at the Harvard Kennedy School’s Belfer Center for Science and International Affairs. Mr. Weber graduated from Cornell University and holds a Master of Science in Foreign Service (MSFS) degree from Georgetown University. He is a member of the Council on Foreign Relations.
Managing Partner, Anzu Partners
David Seldin is a professional investor and advisor with more than thirty years of transactional and management experience. David co-founded Anzu Partners and developed the firm’s focus on deep engagement with portfolio companies. Earlier in his career, David led the effort to win an NFL expansion football team for Jacksonville, Florida and served as the President of the Jacksonville Jaguars NFL franchise through its four-year start up period. Mr. Seldin received a BS in Economics, summa cum laude, from the Wharton School of the University of Pennsylvania, and an MBA from the University of Chicago. David is a director of Nice-Pak Products, Inc. and Anzu portfolio companies Nuburu, Nirrin, TeraPore, AST, Amastan, Zeteo, Edge Embossing, Boston Microfluidics and Liquid Instruments, and a Trustee of Zoo Tampa at Lowry Park.
Managing Principal, Camino Real Capital Partners
Tom Nickoloff, as the founding member of Camino Real Capital Partners, LLC (CRCP), Santa Fe, NM, has been instrumental in building CRCP into a successful equity platform by leveraging his extensive management and technology experience developed in the Oil and Gas industry. Prior to forming CRCP, Mr. Nickoloff founded and served in an executive management capacity for a number of Oil & Gas related entities, most notably TRNCO Petroleum Corporation where he serves as President and Chief Geophysicist. Mr. Nickoloff is Managing Director for BlueStone Venture Partners, an early stage venture capital firm with offices in Santa Fe, NM and Tucson, AZ and serves on the Board of Directors for several technology companies. He has been credited in industry journals and is considered one of the early adopters and innovators in the 3D seismic industry. Tom is a proven technology innovator, successfully recognizing and developing emerging technologies, and has experience building and managing successful business ventures. Tom earned his BSc in Geophysical Engineering from The Colorado School of Mines.